(Credit: Roche ) For the third time, the Food and Drug Administration cleared a cancer drug to treat tumors based on a specific genetic signature rather than by ...

A clinical trial testing a new drug in pancreatic cancer had promising initial results, report researchers from the University of Michigan Rogel Cancer Center. A ph...

Novartis' Zolgensma application contained manipulated data, the FDA says. (Novartis) Novartis’ spinal muscular atrophy gene therapy Zolgensma made...